Navigation Links
ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
Date:6/24/2009

BLACK MOUNTAIN, N.C., June 24 /PRNewswire/ -- ALP Life Sciences, LLC (Company) today announced the Nanoveson(TM) patent has been filed and the Nanoveson(TM) whitepaper is available at www.ALPLifeSciences.com/wp. After completing initial research, the Company is pursuing clinical trials and FDA regulatory approval of Nanoveson(TM) as a prescription drug treatment for non-alcoholic fatty liver disease (NAFLD).

Over 60 million adult Americans suffer from NAFLD and these numbers are rising rapidly. There is no FDA approved NAFLD treatment. NAFLD is a global health crisis. NAFLD is also associated with the metabolic syndrome and other life threatening diseases. NAFLD is known to progress to more advanced liver diseases such as non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis and liver cancer.

Nanoveson(TM) is a novel approach to treating and diagnosing liver diseases and comorbid diseases utilizing the principles of Applied Lipid Polymorphism, which includes a revolutionary application of nanobiotechnology in the area of self-organizing lipid membranes. Nanoveson(TM) therapy utilizes only natural compounds. The therapy triggers liver triglyceride remodeling into bile phospholipids and lipid membrane fusion and aggregation in the intestines. Molecular compounds including biliary phospholipids, arachidonic acid metabolites, cholesterol, methyl metabolites, phthalate esters, and other compounds sequestered in vesicle membranes are expected to be a rich source of disease state biomarkers. Nanoveson(TM) also has the potential to provide extensive support to the life sciences industry in the area of drug metabolism testing.

Research has demonstrated that enterohepatic circulation is the mechanism that maintains quantitative whole body homeostasis of arachidonic acid. T
'/>"/>

SOURCE ALP Life Sciences, LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dow AgroSciences, World Wide Wheat Agree to Collaborate on Wheat
2. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
3. Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery
4. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
5. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
6. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
7. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
10. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ING,Nov.24/PRNewswire-Asia-FirstCall/--LotusPharma...e"Company")agrowingdeveloperand,producerofprescrip...l,productsinthePeople,sRepublicChina,todayreported...jingpharmaceuticaldelegation. ,, Time:Novembe...nter,Chengdu ,, TheBeijingdelegationfeaturesm...
(Date:11/24/2009)...AW,Ind.,Nov.24/PRNewswire-FirstCall/--ZimmerHoldin...articipatinginthe21stAnnualPiperJaffrayHealthCareC...a.m.EasternTime. ,, Alivewebcastofthepresentati...at http://investor.zimmer.com .Thewebcastwillbearc...theCompany ,, Foundedin1927andheadquarteredinW...
(Date:11/24/2009)...IEGO,Nov.24/PRNewswire-FirstCall/--Orexigen®T...companyfocusedonthetreatmentofobesity,todayannounc...heCompany,sBoardofDirectorsgrantedaninducementstoc...onKlassen,M.D.,itsnewlyappointedHeadoftheGlobalCon...incentivestockoptiontotheextentpermittedbylawandha...
Breaking Medicine Technology:Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Work conditions impact parents food choices 9834 1Work conditions impact parents food choices 9834 2Shining a light on disease tracking light emitting bacteria during infection 56496 1California Dental Association to Showcase Critical Role of Dentists in Identifying and Treating Sleep Disorders 56492 1California Dental Association to Showcase Critical Role of Dentists in Identifying and Treating Sleep Disorders 56492 2California Dental Association to Showcase Critical Role of Dentists in Identifying and Treating Sleep Disorders 56492 3
...stic Systems, Inc. (OTC Bulletin Board: SSUR) toda...ent from Inverness Medical Innovations, Inc.,(Amex...ure and Inverness,signed two additional agreements...reby Inverness acquired an option to the exclusive...ertain infectious disease diagnostic,tests develop...
...ERN, Pa., Oct. 17 Cutanea Life Sciences, an,emerg...proving human health,and appearance through the de...diseased and aging skin conditions, today announce...al of Omiganan. The trial compared Omiganan 2.5% ...ulopustular rosacea. Study results demonstrated th...
Other Medicine Technology:StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 2StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 3Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 2Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 3Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 4Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 5Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 6
(Date:11/24/2009)...ire/--NIP,Inc.todayannouncedtheacquisitionofRetire...cutivecompensationandbenefitplanprovidersheadquart...sAngeles,Milwaukee,Boston,ChicagoandAtlanta.RCGwas...heexecutivebenefitsindustry. ,, "Weareexcitedto...antmarketpresence,"statesBillPollock,ChairmanandFo...
(Date:11/24/2009)...ire-USNewswire/--Dr.NelsonEscobar,aphysicianwithth...heJamesBradyAward.TheawardwaspresentedtohimbytheBr...alconferenceonOctober30,2009. ,, Accordingtothe...ionofhisexpertiseinaddressingthecomplexneedsofpers...xceptionalcareofhispatientsandtheirfamiliesastheyr...
(Date:11/24/2009)...FirstCall/--CenteneCorporation(NYSE: CNC )todayann...tedCenteneasoneoftwoCoordinatedCareOrganizationsto...k(MississippiCAN),acoordinatedcareprogramforMissis...Divisiontoexecuteacontractinwhichthecompanywillser...thPlan(Magnolia). ,, BasedinJackson,Miss.,Magno...
(Date:11/24/2009)...er greatly between high- and low-volume centers, s...ay News) -- Do hospitals that conduct the most ang...r patients? Maybe not. , Prior research had sug... to artery-opening procedures, but a new study inv...lume hospitals performing more or less equally. ,...
(Date:11/24/2009)...nds no added use but higher costs , , TU...mer drug ads may contribute to higher Medicaid cos...f the widely used antiplatelet drug clopidogrel (P...5 for 27 state Medicaid programs found that direct...ncrease people,s use of the drug but appeared to b...
Breaking Medicine News(10 mins):Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Advertising to Consumers May Raise Drug Prices 2
...21, 2008 A recent study shows that pre-operative a...cal therapists allow for early diagnosis and succe...cted by the National Naval Medical Center (NNMC) a...e journal, Cancer (April 25, 2008). The authors d...
..., discomfort may be driving factor, study suggests...eople with asthma may be at increased risk for sui... suicidal thoughts without suicide attempts, accor...der, from the U.S. National Comorbidity Survey Rep...
... REVERSE MENTAL ACUITY DEFICITS IN SMOKERS WHO,ARE...view to Address FAA,Ruling on Smoking Cessation Pr... Federal Aviation,Administration (FAA) that it has...this news does not include NRT, which,is deemed sa...
...subgroup of participants in the Womens Health Init...sts that healthy, postmenopausal women whose blood... increased, short-term risk for heart attack when ...) cholesterol to high-density lipoprotein (HDL, or...
...er cells from embryonic stem cells, find clues to ...y 23 (HealthDay News) -- Human liver cells have be... model, hopefully opening the door to help scienti...s that were presented this week at Digestive Disea...
...ompanies establishing online personal health recor...king robotic surgery routine, it makes sense to ha...ursing staff, care managers and other healthcare w...stem. , Akio Koyama of Yamagata University, Japan...
Other Medicine News:Health News:New study shows positive role physical therapists play in lymphedema diagnois and treatment 2Health News:Asthma Associated With Suicidal Thoughts, Attempts 2Health News:MultiVu Video Feed: FREE NICOTINE REPLACEMENT THERAPY (NRT) TO BE OFFERED TO REGISTERED PILOTS INTERESTED IN QUITTING RELIEF IN LIGHT OF RECENT FAA RULINGS 2Health News:Blood cholesterol levels predict risk of heart disease due to hormone therapy 2Health News:New Hope for Liver Diseases 2Health News:New Hope for Liver Diseases 3Health News:Remote-control health 2
...ceMate is the industry's most powerful, comprehens...vailable. In fact, OfficeMate is the most widely u...t of every three computerized eyecare businesses u... practice management needs including patient demog...
Winx Pro Practice Management Software for Eyecare Professionals
E-Z Frame Platinum
VitalWorks Intuition PM Ophthalmology
Medicine Products: